By Notice dated December 21, 2004, and published in the Federal Register on January 4, 2005, (70 FR 391), Eli-Elsohly Laboratories, Inc., Mahmoud A. Elsohly PhD., 5 Industrial Park Drive, Oxford, Mississippi 38655, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Thebaine (9333), a basic class of controlled substance listed in Schedule II.
The company plans to manufacture the listed controlled substance in bulk for use in analysis and drug test standards.
No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Eli-Elsohly Laboratories, Inc. to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Eli-Elsohly Laboratories, Inc., to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with State and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33(a), the above named company is granted registration as a bulk manufacturer of the basic class of controlled substance listed.Start Signature
Dated: March 25, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 05-6699 Filed 4-4-05; 8:45 am]
BILLING CODE 4410-09-P